[1] Melbourne start-up biotech company MecRx can now improve its drug discovery technology after securing a $4 million investment from the Medical Research Commercialization Fund (MRCF).
[2] Through the assistance of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), MecRx is authenticating its technology platform for developing new anti-cancer drugs.
[3] MecRx board director Dr. Chris Smith says MecRx illustrates a great collaboration between the research and commercial sector and the Australian innovation.
Want to keep up with the latest